Mehta BA - Search Results

1

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

Schmidt-Wolf IG, Lefterova P, Mehta BA, Fernandez LP, Huhn D, Blume KG, Weissman IL, Negrin RS. Schmidt-Wolf IG, et al. Among authors: mehta ba. Exp Hematol. 1993 Dec;21(13):1673-9. Exp Hematol. 1993. PMID: 7694868

2

Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells.

Mehta BA, Schmidt-Wolf IG, Weissman IL, Negrin RS. Mehta BA, et al. Blood. 1995 Nov 1;86(9):3493-9. Blood. 1995. PMID: 7579455 Free article.

3

The role of N-linked carbohydrate residues in lymphokine-activated killer cell-mediated cytolysis.

Mehta BA, Collard HR, Negrin RS. Mehta BA, et al. Cell Immunol. 1994 Apr 15;155(1):95-110. doi: 10.1006/cimm.1994.1104. Cell Immunol. 1994. PMID: 7909499

4

Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells.

Schmidt-Wolf IG, Lefterova P, Johnston V, Scheffold C, Csipai M, Mehta BA, Tsuruo T, Huhn D, Negrin RS. Schmidt-Wolf IG, et al. Among authors: mehta ba. Cell Immunol. 1996 Apr 10;169(1):85-90. doi: 10.1006/cimm.1996.0094. Cell Immunol. 1996. PMID: 8612299

5

Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.

Hoyle C, Bangs CD, Chang P, Kamel O, Mehta B, Negrin RS. Hoyle C, et al. Blood. 1998 Nov 1;92(9):3318-27. Blood. 1998. PMID: 9787169 Free article.

6

Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.

Nadkarni JJ, Mehta BA, Koppikar SB, Soman CS, Shrikhande SS, Advani SH. Nadkarni JJ, et al. Among authors: mehta ba. Neoplasma. 1989;36(6):701-8. Neoplasma. 1989. PMID: 2615873

7

In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy.

Mehta BA, Satam MN, Advani SH, Nadkarni JJ. Mehta BA, et al. Cancer Immunol Immunother. 1989;28(2):148-52. doi: 10.1007/BF00199116. Cancer Immunol Immunother. 1989. PMID: 2917365 Free PMC article.

8

Non-Hodgkin's lymphoma: natural cell-mediated cytotoxicity correlated with histological classification and prognosis.

Mehta B, Advani S, Nadkarni J. Mehta B, et al. Oncology. 1989;46(5):323-5. doi: 10.1159/000226741. Oncology. 1989. PMID: 2779947

9

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.

Ramos CA, Rouce R, Robertson CS, Reyna A, Narala N, Vyas G, Mehta B, Zhang H, Dakhova O, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Savoldo B, Dotti G. Ramos CA, et al. Mol Ther. 2018 Dec 5;26(12):2727-2737. doi: 10.1016/j.ymthe.2018.09.009. Epub 2018 Sep 13. Mol Ther. 2018. PMID: 30309819 Free PMC article.

10

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.

Ramos CA, Grover NS, Beaven AW, Lulla PD, Wu MF, Ivanova A, Wang T, Shea TC, Rooney CM, Dittus C, Park SI, Gee AP, Eldridge PW, McKay KL, Mehta B, Cheng CJ, Buchanan FB, Grilley BJ, Morrison K, Brenner MK, Serody JS, Dotti G, Heslop HE, Savoldo B. Ramos CA, et al. J Clin Oncol. 2020 Nov 10;38(32):3794-3804. doi: 10.1200/JCO.20.01342. Epub 2020 Jul 23. J Clin Oncol. 2020. PMID: 32701411 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters